BSX: Summary for Boston Scientific Corporation C - Yahoo Finance

UK Markets closed

Boston Scientific Corporation (BSX)


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
26.38+0.20 (+0.76%)
At close: 4:00PM EDT
People also watch
STJMDTBAXBCRSYK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close26.18
Open26.06
Bid0.00 x
Ask0.00 x
Day's range25.97 - 26.47
52-week range19.67 - 26.47
Volume9,033,424
Avg. volume8,129,233
Market cap36.11B
Beta0.92
PE ratio (TTM)105.52
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents13 hours ago

    Edited Transcript of BSX earnings conference call or presentation 27-Apr-17 12:00pm GMT

    Q1 2017 Boston Scientific Corp Earnings Call

  • Reuters16 hours ago

    Global med-tech firms, India locked in tussle after stent price sting

    NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent.

  • Reuters17 hours ago

    Global med-tech firms, India locked in tussle after stent price sting

    NEW DELHI/MUMBAI, April 28 (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent.